{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "Discontinuation of alprazolam after successful treatment of panic disorder: a naturalistic follow-up study",
    "dc:creator": [
        "ABELSON, J. L",
        "CURTIS, G. C"
    ],
    "dc:relation": "Journal of anxiety disorders -- J. anxiety disord, ISSN 0887-6185, Vol. 7 (2) , pp. 107-117",
    "dc:date": "1993",
    "dc:type": [
        "Text",
        "Article"
    ],
    "dc:language": "English",
    "dc:publisher": "Elsevier",
    "dc:format": [
        "print",
        "18 ref"
    ],
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "Alprazolam"
        },
        {
            "@xml:lang": "fr",
            "#text": "Arrêt traitement"
        },
        {
            "@xml:lang": "fr",
            "#text": "Benzodiazépine dérivé"
        },
        {
            "@xml:lang": "fr",
            "#text": "Chimiothérapie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Etude longitudinale"
        },
        {
            "@xml:lang": "fr",
            "#text": "Evolution"
        },
        {
            "@xml:lang": "fr",
            "#text": "Facteur risque"
        },
        {
            "@xml:lang": "fr",
            "#text": "Homme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Long terme"
        },
        {
            "@xml:lang": "fr",
            "#text": "Marqueur biologique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Panique"
        },
        {
            "@xml:lang": "fr",
            "#text": "Posologie"
        },
        {
            "@xml:lang": "fr",
            "#text": "Psychotrope"
        },
        {
            "@xml:lang": "fr",
            "#text": "Recidive"
        },
        {
            "@xml:lang": "fr",
            "#text": "Système hypothalamohypophysosurrénalien"
        },
        {
            "@xml:lang": "fr",
            "#text": "Tranquillisant"
        },
        {
            "@xml:lang": "fr",
            "#text": "Trouble anxieux"
        },
        {
            "@xml:lang": "en",
            "#text": "Withdrawal"
        },
        {
            "@xml:lang": "en",
            "#text": "Benzodiazepine derivatives"
        },
        {
            "@xml:lang": "en",
            "#text": "Chemotherapy"
        },
        {
            "@xml:lang": "en",
            "#text": "Follow up study"
        },
        {
            "@xml:lang": "en",
            "#text": "Evolution"
        },
        {
            "@xml:lang": "en",
            "#text": "Risk factor"
        },
        {
            "@xml:lang": "en",
            "#text": "Human"
        },
        {
            "@xml:lang": "en",
            "#text": "Long term"
        },
        {
            "@xml:lang": "en",
            "#text": "Biological marker"
        },
        {
            "@xml:lang": "en",
            "#text": "Panic"
        },
        {
            "@xml:lang": "en",
            "#text": "Posology"
        },
        {
            "@xml:lang": "en",
            "#text": "Psychotropic"
        },
        {
            "@xml:lang": "en",
            "#text": "Relapse"
        },
        {
            "@xml:lang": "en",
            "#text": "Hypothalamohypophysoadrenal axis"
        },
        {
            "@xml:lang": "en",
            "#text": "Tranquillizer"
        },
        {
            "@xml:lang": "en",
            "#text": "Anxiety disorder"
        },
        {
            "@xml:lang": "es",
            "#text": "Paro tratamiento"
        },
        {
            "@xml:lang": "es",
            "#text": "Benzodiazepina derivado"
        },
        {
            "@xml:lang": "es",
            "#text": "Quimioterapia"
        },
        {
            "@xml:lang": "es",
            "#text": "Estudio longitudinal"
        },
        {
            "@xml:lang": "es",
            "#text": "Evolución"
        },
        {
            "@xml:lang": "es",
            "#text": "Factor riesgo"
        },
        {
            "@xml:lang": "es",
            "#text": "Hombre"
        },
        {
            "@xml:lang": "es",
            "#text": "Largo plazo"
        },
        {
            "@xml:lang": "es",
            "#text": "Marcador biológico"
        },
        {
            "@xml:lang": "es",
            "#text": "Pánico"
        },
        {
            "@xml:lang": "es",
            "#text": "Posología"
        },
        {
            "@xml:lang": "es",
            "#text": "Psicotropo"
        },
        {
            "@xml:lang": "es",
            "#text": "Recaida"
        },
        {
            "@xml:lang": "es",
            "#text": "Sistema hipotalamohipofisosuprarrenal"
        },
        {
            "@xml:lang": "es",
            "#text": "Tranquilizante"
        },
        "002B02B03: Psycholeptiques: tranquillisant, neuroleptique. / Psycholeptics: tranquillizer, neuroleptic.",
        "770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry",
        "770-E: Psychopharmacologie / Psychopharmacology"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number 4693365"
}